Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Gladstone Capital Corporation is an asset management business based in the US. Gladstone Capital Corporation shares (GLAD) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$11.59|
|52-week range||$6.50 - $11.91|
|50-day moving average||$11.42|
|200-day moving average||$11.28|
|Wall St. target price||$9.50|
|Dividend yield||$0.78 (6.85%)|
|Earnings per share (TTM)||$1.90|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||1.40%|
|1 month (2021-09-23)||1.67%|
|3 months (2021-07-23)||1.93%|
|6 months (2021-04-23)||7.61%|
|1 year (2020-10-22)||53.71%|
|2 years (2019-10-22)||18.99%|
|3 years (2018-10-22)||27.22%|
|5 years (2016-10-21)||39.47%|
Valuing Gladstone Capital Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Gladstone Capital Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Gladstone Capital Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Gladstone Capital Corporation shares trade at around 6x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Gladstone Capital Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.8632. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Gladstone Capital Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$52 million|
|Operating margin TTM||72.48%|
|Gross profit TTM||$48 million|
|Return on assets TTM||4.85%|
|Return on equity TTM||23.81%|
|Market capitalisation||$392.1 million|
TTM: trailing 12 months
There are currently 256,712 Gladstone Capital Corporation shares held short by investors – that's known as Gladstone Capital Corporation's "short interest". This figure is 11.3% down from 289,501 last month.
There are a few different ways that this level of interest in shorting Gladstone Capital Corporation shares can be evaluated.
Gladstone Capital Corporation's "short interest ratio" (SIR) is the quantity of Gladstone Capital Corporation shares currently shorted divided by the average quantity of Gladstone Capital Corporation shares traded daily (recently around 132325.77319588). Gladstone Capital Corporation's SIR currently stands at 1.94. In other words for every 100,000 Gladstone Capital Corporation shares traded daily on the market, roughly 1940 shares are currently held short.
However Gladstone Capital Corporation's short interest can also be evaluated against the total number of Gladstone Capital Corporation shares, or, against the total number of tradable Gladstone Capital Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Gladstone Capital Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Gladstone Capital Corporation shares in existence, roughly 10 shares are currently held short) or 0.0079% of the tradable shares (for every 100,000 tradable Gladstone Capital Corporation shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Gladstone Capital Corporation.
Find out more about how you can short Gladstone Capital Corporation stock.
Dividend payout ratio: 32.7% of net profits
Recently Gladstone Capital Corporation has paid out, on average, around 32.7% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 6.82% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Gladstone Capital Corporation shareholders could enjoy a 6.82% return on their shares, in the form of dividend payments. In Gladstone Capital Corporation's case, that would currently equate to about $0.78 per share.
While Gladstone Capital Corporation's payout ratio might seem fairly standard, it's worth remembering that Gladstone Capital Corporation may be investing much of the rest of its net profits in future growth.
Gladstone Capital Corporation's most recent dividend payout was on 29 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 20 October 2021 (the "ex-dividend date").
Over the last 12 months, Gladstone Capital Corporation's shares have ranged in value from as little as $6.501 up to $11.906. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Gladstone Capital Corporation's is 1.4233. This would suggest that Gladstone Capital Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Gladstone Capital Corporation is a private equity and a venture capital fund specializing in lower middle market, growth capital, add on acquisitions, debt investments in senior loans, second lien loans, senior subordinated loans, junior subordinated loans, and mezzanine loans and equity investments in the form of common stock, preferred stock, limited liability company interests, or warrants. It operates as a business development company. The fund also makes private equity investments in acquisitions, buyouts and recapitalizations, and refinancing existing debts. It targets small and medium-sized companies in United States. It invests in companies engaged in the business services, light and specialty manufacturing, niche industrial products and services, specialty consumer products and services, energy services, transportation and logistics, healthcare and education services, specialty chemicals, media and communications and aerospace and defense. The fund seeks to invest between $7 million and $30 million in companies that have between $20 million and $150 million in sales and EBITDA between $3 million and $25 million. It prefers to acquire minority stakes.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.